Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation
- 浏览1
Journal of Clinical Oncology
2350-2361页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



